期刊文献+

妊娠合并抗磷脂综合征诊疗进展 被引量:10

下载PDF
导出
摘要 抗磷脂综合征是以抗磷脂抗体介导的,以动静脉血栓形成、病理妊娠或血小板减少为临床表现特征的一系列综合征。近年来,妊娠合并抗磷脂综合征导致的不良母胎结局愈加引起重视。对妊娠合并抗磷脂综合征的患者及早诊断及治疗,可大幅减少不良母胎结局,本文对抗磷脂综合征在产科领域的诊疗作一综述。 Antiphospholipid syndrome(APS)is a series of syndromes caused by anti-phospholipid antibodies(aPLs)characterized by arteriovenous thrombosis,pathological pregnancy or thrombocytopenia.In recent years,the adverse maternal and fetal outcomes caused by pregnancy combined with antiphospholipid syndrome have become more and more important.Early diagnosis and treatment of patients with pregnancy combined with antiphospholipid syndrome can greatly reduce the bad maternal and fetal outcomes.This paper summarizes the new progress in the diagnosis and treatment of phospholipid syndrome in obstetrics.
出处 《妇产与遗传(电子版)》 2018年第4期48-53,共6页 Obstetrics-Gynecology and Genetics (Electronic Edition)
关键词 抗磷脂综合征 妊娠 抗磷脂抗体 抗凝治疗 免疫调节治疗 Antiphospholipid syndrome Pregnancy Antiphos-pholipid antibodies Anticoagulation Immunoregulation
  • 相关文献

参考文献6

二级参考文献26

  • 1Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease ex- pression in a cohort of 1 000 patients[ J]. Arthritis Rheum, 2002, 46(4) : 1019 - 1027.
  • 2Tincani A, Bazzani C, Zingarelli S, et al. Lupus and the an- tiphospholipid syndrome in pregnancy and obstetrics : clinical char- acteristics, diagnosis, pathogenesis, and treatment I J]. Semin Thromb Hemost, 2008, 34 (3) : 267 -273.
  • 3Cervera R, Khamashta MA, Shoenfeld Y, et al. Morbidity and mortality in the antiphospholi-pid syndrome during a 5-year period : a multicentre prospective study of 1000 patients [ J ]. Ann Rheum Dis, 2009, 68(9) : 1428 -1432.
  • 4Galarza-Maldonado C, Kourilovitch MR, Perez-Fernandez OM, et al. Obstetric antiphospholipid syndrome [ J ]. Antoimmun Rev, 2012, 11 : 288 -295.
  • 5Farquharson RG, Quenby S, Greaves M. Antiphospholipid syn- drome in pregnancy: a randomized, controlled trial of treatment [J]. Obstet Gynecol, 2002, 100(4) : 408 -413.
  • 6Derksen RH, de Groot PG. The obstetric antiphospholipid syn- drome[ J ]. J Reprod Immunol, 2008, 77 ( 1 ) : 41 - 50.
  • 7Fouda UM, Sayed AM, Ramadan DI, et al. Efficacy and safety oftwo doses of low molecular weight heparin (enoxaparin) in preg- nant women with a history of recurrent abortion secondary to an- tiphospholipid syndrome[J]. J Obstet Gynaecol, 2010, 30 (8) : 842 - 846.
  • 8Ruffatti A, Tonello M, Cavazzana A, et al. Laboratory classifica- tion categories and pregnancy outcome in patients with primary an- tiphospholipid syndrome prescribed antithrombotic therapy [ J ]. Thromb Res, 2009, 123(3) : 482 -487.
  • 9Ruffatti A, Tonello M, Visentin MS, et al. Risk factors for preg- nancy failure in patients with anti-phospholipid syndrome treated with conventional therapies : a multicentre, case-control study [ J ]. Rheumatology (Oxford), 2011,50(9): 1684-1689.
  • 10Simchen M J, Dulitzki M, Rofe G, et al. High positive antibody ti- ters and adverse pregnancy outcome in women with antiphospholi- pid syndrome[ J ]. Acta Obstet Gynecol Scand, 2011, 90 ( 12 ) : 1428 - 1433.

共引文献185

同被引文献87

引证文献10

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部